These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 410716)

  • 21. Trimethoprim in pediatric urinary tract infection.
    Rajkumar S; Saxena Y; Rajagopal V; Sierra MF
    Child Nephrol Urol; 1988-1989; 9(1-2):77-81. PubMed ID: 3251626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriological evaluation of the course of urinary tract infections treated with trimethoprim and-or sulphamethoxazole.
    Knudsen JB; Korner B; Reinicke V; Stahl D; Thomsen AC
    Acta Chir Scand Suppl; 1973; 433():102-9. PubMed ID: 4575140
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy and tolerance of trimethoprim/sulfamethoxazole administered intramuscularly in patients with urinary tract infections (author's transl)].
    Westenfelder M; Reinhardt W; Sommerkamp H; Bollack C
    Infection; 1980; 8 Suppl 3():S 347-9. PubMed ID: 7409889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
    Ronald AR; Harding CK; Mathias R; Wong CK; Muir P
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):13-6. PubMed ID: 1137829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of urinary tract infections with trimethoprim-sulfamethoxazole in diabetics].
    Talaulicar M; Willms B
    MMW Munch Med Wochenschr; 1979 Jan; 121(1):33-4. PubMed ID: 102994
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulphamethoxazole-trimethoprim. III. Clinical aspects. Urinary-tract infections. Summary.
    Ornsten PA
    Scand J Infect Dis Suppl; 1976; (8):71-4. PubMed ID: 779007
    [No Abstract]   [Full Text] [Related]  

  • 28. Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli.
    France AM; Kugeler KM; Freeman A; Zalewski CA; Blahna M; Zhang L; Marrs CF; Foxman B
    Clin Infect Dis; 2005 Apr; 40(8):1101-7. PubMed ID: 15791508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 31. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
    Le TP; Miller LG
    Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urinary tract infections in general practice. III. Treatment with sulphamethizole, trimethoprim or co-trimazin (sulphadiazine-trimethoprim].
    Mabeck CE; Vejlsgaard R
    Ugeskr Laeger; 1980 Jun; 142(26):1664-8. PubMed ID: 6996257
    [No Abstract]   [Full Text] [Related]  

  • 33. [Short-term therapy of urinary tract infections with a combination of trimethoprim and sulfamethoxazole].
    Prát V
    Cas Lek Cesk; 1971 Oct; 110(43):1000-3. PubMed ID: 4939127
    [No Abstract]   [Full Text] [Related]  

  • 34. Cinoxacin and trimethoprim with sulfamethoxazole in the treatment of infections of the urinary tract: a clinical comparison.
    Finkelstein LH; Arsht DB; Manfrey SJ
    J Am Osteopath Assoc; 1982 Aug; 81(12):843-5. PubMed ID: 7129972
    [No Abstract]   [Full Text] [Related]  

  • 35. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo].
    Böhni E
    Chemotherapy; 1969; 14():Suppl:1-21. PubMed ID: 4908562
    [No Abstract]   [Full Text] [Related]  

  • 39. Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo.
    Acar JF; Goldstein F; Chabbert YA
    J Infect Dis; 1973 Nov; 128():Suppl:470-7 p. PubMed ID: 4585953
    [No Abstract]   [Full Text] [Related]  

  • 40. Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.
    Forbes PA; Drummond KN
    J Infect Dis; 1973 Nov; 128():Suppl:626-8 p. PubMed ID: 4585961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.